Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VolitionRX Ltd VNRX

Healthcare Medical Instruments & Supplies
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and... see more

Recent & Breaking News (NYSEAM:VNRX)

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

GlobeNewswire March 29, 2021

Sidoti Virtual Investor Conference

Accesswire March 23, 2021

VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and Business Update

PR Newswire March 22, 2021

VolitionRx Limited to Webcast Live at Life Sciences Investor Forum March 25th

GlobeNewswire March 22, 2021

VolitionRx Limited Announces Participation in the Benzinga Biotech Small Cap Conference

Newsfile March 19, 2021

Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

GlobeNewswire March 19, 2021

New Data Demonstrates Nu.Q® is Effective in Monitoring Treatment of Sepsis

PR Newswire March 17, 2021

VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update

PR Newswire March 16, 2021

VolitionRx Limited to Present at Conferences in March 2021

PR Newswire March 8, 2021

VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock

PR Newswire February 12, 2021

VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock

PR Newswire February 10, 2021

VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock

PR Newswire February 9, 2021

Small and Microcap Company Investor Presentations Now Available for On-Demand Viewing

Canada NewsWire February 8, 2021

VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts

PR Newswire February 2, 2021

VolitionRx Limited to Webcast Live at VirtualInvestorConferences.com February 4th

PR Newswire February 1, 2021

Live Investor Conference & Webinar: Small and Microcap Company Showcase on February 4th

Canada NewsWire January 28, 2021

National Taiwan University Hospital Presents Data on Nu.Q(TM) Assay Performance at the World Conference on Lung Cancer

PR Newswire January 28, 2021

VolitionRx Limited Opens its New Manufacturing Facility in Belgium

PR Newswire January 25, 2021

VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding

PR Newswire January 6, 2021

Life Sciences Company Investor Presentations Now Available for On-Demand Viewing

GlobeNewswire December 21, 2020